Merck (NYSE: MRK) completed its acquisition of Verona Pharma plc (NASDAQ: VRNA) for approximately $10 billion, the company announced. Under ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE